Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI

Genetic variability has been shown to affect statin responsiveness. Participants from the Utrecht Cardiovascular Pharmacogenetics (UCP) studies were enrolled from a population-based registry of pharmacy records linked to hospital discharge records (PHARMO) to investigate tagging SNPs within candidat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Peters, Bas J.M., Pett, Helmi, Klungel, Olaf H., Stricker, Bruno H. Ch., Psaty, Bruce M., Glazer, Nicole L., Wiggins, Kerri L., Bis, Josh C., de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3465613/
https://ncbi.nlm.nih.gov/pubmed/21741043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2011.06.023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars